Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Slides:

Advertisements

Similar presentations

Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.

Advertisements

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

The “occasional open heart surgeon” revisited

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

The challenge of achieving 1% operative mortality for coronary artery bypass grafting: A multi-institution Society of Thoracic Surgeons Database analysis

Manuel Caceres, MD, Darryl S. Weiman, MD, JD

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting Danny Chu, MD, Faisal.

Damien J. LaPar, MD, MSc, Carlos M. Mery, MD, MPH, Benjamin D

Fred H. Edwards, MD, David M. Shahian, MD, Maria V

Stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: A meta-analysis of comparative studies Hisato Takagi,

C-reactive protein and coronary events following percutaneous coronary angioplasty Robbert J de Winter, MD, PhD, Karel T Koch, MD, PhD, Jan P van Straalen,

J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K

Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);

Myocardial Revascularization for Patients With Diabetes: Coronary Artery Bypass Grafting or Percutaneous Coronary Intervention? Serenella Castelvecchio,

Building a bioartificial heart: A 3-song saga

Jeffrey G. Gaca, MD, Shubin Sheng, PhD, Mani A

Right internal thoracic artery or saphenous vein grafting

Which is more important in the potential interference on cardioprotection by remote ischemic preconditioning: β-blockers or anesthetic choice? Yang Liu,

Long-Term Survival of Patients With Ischemic Cardiomyopathy Treated by Coronary Artery Bypass Grafting Versus Medical Therapy Eric J. Velazquez, MD,

Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: An updated meta-analysis.

Three-Year Outcomes of Multivessel Revascularization in Very Elderly Acute Coronary Syndrome Patients Brett C. Sheridan, MD, Sally C. Stearns, PhD, Joseph.

Defining operative mortality: Impact on outcome reporting

Why surgery won the SYNTAX trial and why it matters

Zhe Zheng, MD, PhD, Heng Zhang, MD, PhD, Bo Xu, MBBS

Michael E. Halkos, MD, MSc, Henry A

Coronary artery bypass in patients with type 2 diabetes: Experience from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial Edward.

Multilevel data analysis: What? Why? How?

How should we treat air leaks?

Harold L. Lazar, MD The Journal of Thoracic and Cardiovascular Surgery

Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Toshihiro Fukui,

Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial Umberto Benedetto, MD, PhD, Douglas G. Altman,

Surgical economics: MACRA, MIPS, and bundles—Lessons learned in the first 3 years of a coronary artery bypass grafting alternative payment model Daniel.

Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: When is preoperative coronary angiography necessary? Nassir M.

Hisato Takagi, MD, PhD, Hideaki Manabe, MD, Takuya Umemoto, MD, PhD

Optimal timing of coronary artery bypass after acute myocardial infarction: A review of California discharge data Eric S. Weiss, MD, David D. Chang,

A decade after the Surgical Treatment for Ischemic Heart Failure (STICH) trial: Weaving firm clinical recommendations from lessons learned Robert E.

The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation David.

Open aortic arch reconstruction after previous cardiac surgery: Outcomes of 168 consecutive operations Eduard Quintana, MD, FETCS, Pietro Bajona, MD,

A protocol-driven approach to early extubation after heart surgery

It's not “just a shunt” but sometimes it should be…

For everything there is a season

Peter K. Smith, MD, Robert M. Califf, MD, Robert H

Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease Neuza Helena Lopes, MD, PhD, Felipe da Silva Paulitsch, MD,

To bypass or stent? The changing rules of an advancing game

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Derrick Y. Tam, MD, Stephen E. Fremes, MD, MSc

Mitral Valve Repair for Degenerative Disease: A 20-Year Experience

Hisato Takagi, MD, PhD, Takuya Umemoto, MD, PhD

Early and Midterm Results of Off-Pump Coronary Artery Bypass Grafting

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Ralph S. Mosca, MD The Journal of Thoracic and Cardiovascular Surgery

Occult renal dysfunction: a mortality and morbidity risk factor in coronary artery bypass grafting surgery Antonio Miceli, MD, Vito D. Bruno, MD, Radek.

Risk stratification and prognostic effects of internal thoracic artery grafting during acute myocardial infarction Manuel Caceres, MD, Xia He, MS, James.

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Comparison of 30-day outcomes of coronary artery bypass grafting surgery verus hybrid coronary revascularization stratified by SYNTAX and euroSCORE Marzia.

The future of cardiac surgery training: A survival guide

Improved quality and cost-effectiveness of coronary artery bypass grafting in the United States from 1988 to 2005 Howard K. Song, MD, PhD, Brian S. Diggs,

Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.

Improved Long-Term Survival for Diabetic Patients With Surgical Versus Interventional Revascularization Paul Kurlansky, MD, Morley Herbert, PhD, Syma.

“The more things change…”: The challenges ahead

Apples remain apples NO matter what

A large international single-center case-series of coronary artery fistulas in children: When high clinical research standards adopted globally create.

Preoperative PFTs: The answer is blowing in the wind

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

The relationship between perioperative temperature and adverse outcomes after off- pump coronary artery bypass graft surgery Edward L. Hannan, PhD, Zaza.

G. Chad Hughes, MD, Yue Zhao, PhD, J. Scott Rankin, MD, John E

Time-related mortality for women after coronary artery bypass graft surgery: a population-based study Veena Guru, MD, Stephen E Fremes, MD, MSc, Jack.

IS local wound infection rate more important than long-term graft patency in coronary artery bypass grafting? Tomislav Kopjar, MD, PhD, Michael R. Dashwood,

Presentation transcript:

Twenty-five-year outcomes after multiple internal thoracic artery bypass Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A. Daneshmand, MD, Jeffrey G. Gaca, MD, Carmelo A. Milano, MD, Donald D. Glower, MD, Peter K. Smith, MD The Journal of Thoracic and Cardiovascular Surgery Volume 145, Issue 4, Pages 970-975 (April 2013) DOI: 10.1016/j.jtcvs.2012.11.093 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Unadjusted cumulative incidence data: nonfatal MI (A), PCI (B), redo CABG (C), and all-cause mortality (D). Number of patients at risk is shown in Figure 3. MI, Myocardial infarction; PCI, percutaneous coronary intervention; MITA, multiple internal thoracic artery; SITA, single internal thoracic artery; NITA, no internal thoracic artery; CABG, coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 970-975DOI: (10.1016/j.jtcvs.2012.11.093) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Risk-adjusted cumulative incidence data: nonfatal MI (A), PCI (B), redo CABG (C), and all-cause mortality (D). Number of patients at risk is shown in Figure 3. MI, Myocardial infarction; PCI, percutaneous coronary intervention; MITA, multiple internal thoracic artery; SITA, single internal thoracic artery; NITA, no internal thoracic artery; CABG, coronary artery bypass grafting. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 970-975DOI: (10.1016/j.jtcvs.2012.11.093) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Event-free survival probability for composite outcome: unadjusted (A) and risk-adjusted (B) data. MITA, Multiple internal thoracic artery; SITA, single internal thoracic artery; NITA, no internal thoracic artery. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 970-975DOI: (10.1016/j.jtcvs.2012.11.093) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions